People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aulos Bioscience, Inc. | — | Biotechnology | Series A | $20.0M | $41.1M | 2020 |
| Replicate Bioscience, Inc. | — | Biotechnology | Series B | $20.0M | $614.8M | 2021 |
| Marlinspike Therapeutics, Inc. | — | Biotechnology | Seed | $3.5M | $64.4M | 2022 |
Joseph Yanchik at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph Yanchik on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Seth Harrison | 3 | 19 |
| Michael Ehlers | 2 | 6 |
| Yechezkel Barenholz | 1 | 3 |
| Yanay Ofran | 1 | 2 |
| Anna Batarina | 1 | 2 |
| Rajesh Chopra | 1 | 2 |
| Nathaniel Wang | 1 | 1 |
| Alexander McCampbell | 1 | 1 |
| Raj Chopra | 1 | 1 |
| Aron Knickerbocker | 1 | 1 |
| James J. Vasselli | 1 | 1 |
| Mace Rothenberg | 1 | 1 |
| Leo J. Redmond | 1 | 1 |
| Micah Pearlman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.